Quick Answer
ABVC BIOPHARMA, INC. reported Common Stock Shares Outstanding of 25.05 million shares for the year ending 2025.
- ABVC BIOPHARMA, INC. showed an increase of +80.6% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from ABVC BIOPHARMA, INC.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2011 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2011 to 2025), ABVC BIOPHARMA, INC.'s Common Stock Shares Outstanding has grown by 76.9%.
- Historical annual values: Fiscal year 2025: 25.05 million shares | Fiscal year 2024: 13.87 million shares | Fiscal year 2023: 7.94 million shares | Fiscal year 2022: 3.29 million shares | Fiscal year 2021: 24.42 million shares | Fiscal year 2020: 24.42 million shares | Fiscal year 2019: 19.48 million shares | Fiscal year 2018: 11.88 million shares | Fiscal year 2017: 213.75 million shares | Fiscal year 2017: 213.75 million shares | Fiscal year 2016: 210.82 million shares | Fiscal year 2015: 166.27 million shares | Fiscal year 2014: 11,144 shares | Fiscal year 2013: 54.59 million shares | Fiscal year 2012: 14.16 million shares | Fiscal year 2011: 14.16 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: